English | Español

Regulatory
+ Regulatory
Patient Daily | May 31, 2024

US Reps. Bucshon, Carter, Harshbarger introduce legislation for transparency of 340B drug program
+ Pharmaceuticals
Patient Daily | May 31, 2024

Mayo Clinic names Gelareh Zadeh new chair for Department of Neurosurgery
+ Pharmaceuticals
Patient Daily | May 31, 2024

Oakton College partners with Northwestern Medicine on medical assistant apprenticeship
+ Pharmaceuticals
Patient Daily | May 30, 2024

Experts warn against harmful effects of sugary beverages on dental health
+ Pharmaceuticals
Patient Daily | May 30, 2024

New platform aids real-time brain cancer diagnosis during surgery
+ Pharmaceuticals
Patient Daily | May 30, 2024

Mayo Clinic to present key studies at ASCO 2024
+ Pharmaceuticals
Patient Daily | May 29, 2024

Protein hnRNPM crucial for cellular integrity in protein production
+ Pharmaceuticals
Patient Daily | May 29, 2024

Baylor College celebrates Class of 2024 commencement

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation